IL1B and rheumatoid arthritis: The present study demonstrated that the formulation reduced serum levels of IL-1β, IL-6, and TNF-α, suggesting that its anti-RA effects may involve downregulating inflammatory cytokine production and alleviating paw swelling, thus exerting anti-inflammatory and immunomodulatory actions [29].